Siro Clinpharm Private Limited

Global healthcare solutions provider for drug development and clinical trials.

2000 | Mumbai, Maharashtra (India) | Active
Last Updated: October 24, 2024

Siro Clinpharm Profile

Key Indicators

  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 0.61 M
  • Company Age 24 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 2.37 Cr
  • Satisfied Charges ₹ 119.93 Cr
  • Revenue Growth 33.99%
  • Profit Growth 467.04%
  • Ebitda -76.90%
  • Net Worth 245.67%
  • Total Assets 140.24%

About Siro Clinpharm

Siro Clinpharm Private Limited (SCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 March 2000 and has a history of 24 years and ten months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 0.61 M.

The company currently has active open charges totaling ₹2.37 Cr. The company has closed loans amounting to ₹119.93 Cr, as per Ministry of Corporate Affairs (MCA) records.

Gautam Daftary, Akshay Daftary, and Karan Daftary serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2000PTC125061

  • Company No.

    125061

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Mar 2000

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Siro Clinpharm Private Limited offer?

Siro Clinpharm Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Risk Management Services, Data Entry & Data Processing Service, Data Management, Language Translation Service, Copywriting & Content Development, Content Writing Service, Data Processing, Examination Data Processing.

Who are the key members and board of directors at Siro Clinpharm?

Board Members (3)

NameDesignationAppointment DateStatus
Karan Daftary Country flag representing In Whole-Time Director 12-Sep-2018Current
Gautam Daftary Country flag representing In Director 21-Mar-2000Current
Akshay Daftary Country flag representing In Director 12-Feb-2018Current

Financial Performance of Siro Clinpharm.

Siro Clinpharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.99% increase. The company also saw a substantial improvement in profitability, with a 467.04% increase in profit. The company's net worth Soared by an impressive increase of 245.67%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
33.99%
Revenue from Operations
17.37%
Total Assets
140.24%
Profit or Loss
467.04%
Net Worth
245.67%
EBITDA
-76.90%

What is the Ownership and Shareholding Structure of Siro Clinpharm?

In 2023, Siro Clinpharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.37 Cr

Satisfied Charges

₹119.93 Cr

Charges Breakdown by Lending Institutions

  • Others : 2.37 Cr

Latest Charge Details

DateLenderAmountStatus
27 Mar 2024Others₹1.37 CrOpen
24 Nov 2021Others₹1.00 CrOpen
12 Mar 2019Others₹4.50 CrSatisfied
12 Mar 2019Others₹5.50 CrSatisfied
26 Oct 2017Others₹5.00 MSatisfied

How Many Employees Work at Siro Clinpharm?

Siro Clinpharm has a workforce of 258 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Siro Clinpharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siro Clinpharm's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Siro Clinpharm

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100910202 was registered on 27 Mar 2024.

    27 Mar 2024

  • Annual General Meeting

    Siro Clinpharm Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Siro Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Charges

    A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100517853 was registered on 24 Nov 2021.

    24 Nov 2021

  • Charges

    A charge registered on 26 Oct 2017 via Charge ID 100159408 with Others was fully satisfied on 08 Nov 2021.

    08 Nov 2021

  • Charges

    A charge registered on 12 Mar 2019 via Charge ID 100247782 with Others was fully satisfied on 18 May 2021.

    18 May 2021

Recent News, Updates & Announcement

Frequently asked questions

  • Siro Clinpharm Private Limited was incorporated on 21 Mar 2000.

  • The authorized share capital of Siro Clinpharm Private Limited is ₹ 25.00 Cr and paid-up capital is ₹ 0.61 M.

  • Currently 3 directors are associated with Siro Clinpharm Private Limited.

    • Gautam Vinod Daftary
    • Akshay Gautam Daftary
    • Karan Gautam Daftary
  • As per Ministry of Corporate Affairs (Mca), the registered address of Siro Clinpharm Private Limited is 16Th Floor Hoechst House Nariman Point, City India, Mumbai, Maharashtra, 400021.

  • The corporate identification number (CIN) of Siro Clinpharm Private Limited is U24230MH2000PTC125061 and the company number is 125061 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Siro Clinpharm Private Limited is https://www.siroclinpharm.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Siro Clinpharm Private Limited has risen by 33.99%.

  • As Per 2023 financial reports, 258 employees are currently employed by Siro Clinpharm Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Siro Clinpharm Private Limited has experienced an upsurge of 245.67%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Siro Clinpharm Private Limited amount to ₹ 2.37 Cr.

  • The most recent Balance Sheet for Siro Clinpharm Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development